sphrei.org - SphReI—Sphenome Research Institute | Proposes the Launch of SphReI-HxVaccine Global Trial

Description: SphReI-HxVaccine is an innovative, multi-center, global trial platform, is now open for enrollment for evaluation purposes as we prepare submissions into applicable regulatory agencies. We declare that the iatrogenic-phase disease-vector is different from the natural phase of COVID-19 in its method of spread, disease manifestations and mortality indicators. Many countries have suffered substantial losses. In spite of clear data favoring population-behavior modifications as being the single largest determina

healthcare (5794) covid-19 (2724) infrastructure (1362) vaccine (285) clinical trial (170)

Example domain paragraphs

The world's first AI—enhanced protection grid—shieldSpace.ai is working with governments to deploy a 360°, 24x7x365 protection-grid across six levels against outbreak of pathogens—viral, bacterial, other virulent vectors—and diseases. shieldSpace.ai pursues a dual strategy of decontamination & treatment in parallel to combat the pandemic. shieldSpace.AI is a promising initiative to protect humanity from stressors on Earth and in/from Space.

Moolex is rapidly engaging partners and industry partners to engage in developing earthships. Base models include 500 meter wide, propelled with HxFuel and Spheon Turbine engines capable of carrying 10,000 metric tonnes of payload at launch. 15 floors of passenger amenities can safely accommodate 2500 passengers to and from Auvura ports on Earth at Mach 10 and more. Moolex has identified signature of special alloys available in asteroids and close-by planets. These alloys along with advances from ongoing re

Links to sphrei.org (1)